Riley Brigit 4
4 · Adverum Biotechnologies, Inc. · Filed Mar 17, 2022
Insider Transaction Report
Form 4
Riley Brigit
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-08+195,000→ 195,000 totalExercise: $1.29Exp: 2032-03-07→ Common Stock (195,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of February 18, 2022 (the "Vesting Commencement Date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.